PMID- 22009371 OWN - NLM STAT- MEDLINE DCOM- 20120229 LR - 20181217 IS - 1439-4286 (Electronic) IS - 0018-5043 (Linking) VI - 43 IP - 11 DP - 2011 Oct TI - Mechanisms of p-methoxycinnamic acid-induced increase in insulin secretion. PG - 766-73 LID - 10.1055/s-0031-1287793 [doi] AB - p-Methoxycinnamic acid (p-MCA) is a cinnamic acid derivative that shows various pharmacologic actions such as hepatoprotective and antihyperglycemic activities. The present study was to elucidate the mechanisms by which p-MCA increases [Ca(2)(+)]i and insulin secretion in INS-1 cells. p-MCA (100 muM) increased [Ca(2)(+)]i in INS-1 cells. The p-MCA-induced insulin secretion and rise in [Ca(2)(+)]i were markedly inhibited in the absence of extracellular Ca(2)(+) or in the presence of an L-type Ca(2)(+) channel blocker nimodipine. These results suggested that p-MCA increased Ca(2)(+) influx via the L-type Ca(2)(+) channels. Diazoxide, an ATP-sensitive K(+) channel opener, did not alter p-MCA-induced insulin secretion, nor [Ca(2)(+)]i response. In addition, p-MCA enhanced glucose-, glibenclamide-induced insulin secretion whereas it also potentiated the increase in insulin secretion induced by arginine, and Bay K 8644, an L-type Ca(2)(+) channel agonist. Taken together, our results suggest that p-MCA stimulated insulin secretion from pancreatic beta-cells by increasing Ca(2)(+) influx via the L-type Ca(2)(+) channels, but not through the closure of ATP-sensitive K(+) channels. CI - (c) Georg Thieme Verlag KG Stuttgart . New York. FAU - Adisakwattana, S AU - Adisakwattana S AD - Department of Pharmacology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand. FAU - Hsu, W H AU - Hsu WH FAU - Yibchok-anun, S AU - Yibchok-anun S LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20111018 PL - Germany TA - Horm Metab Res JT - Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme JID - 0177722 RN - 0 (Calcium Channel Agonists) RN - 0 (Calcium Channel Blockers) RN - 0 (Calcium Channels, L-Type) RN - 0 (Cinnamates) RN - 0 (Hypoglycemic Agents) RN - 0 (Insulin) RN - 0 (KATP Channels) RN - 0 (Membrane Transport Modulators) RN - 6G4ML8401A (4-methoxycinnamic acid) RN - 94ZLA3W45F (Arginine) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Animals MH - Arginine/metabolism MH - Calcium Channel Agonists/pharmacology MH - Calcium Channel Blockers/pharmacology MH - Calcium Channels, L-Type/chemistry MH - Calcium Signaling/drug effects MH - Cell Line MH - Cinnamates/*pharmacology MH - Glucose/metabolism MH - Hypoglycemic Agents/*pharmacology MH - Insulin/*metabolism MH - Insulin Secretion MH - Insulin-Secreting Cells/*drug effects/*metabolism MH - KATP Channels/antagonists & inhibitors MH - Kinetics MH - Male MH - Membrane Transport Modulators/pharmacology MH - Perfusion MH - Rats MH - Rats, Sprague-Dawley MH - Secretory Pathway/drug effects EDAT- 2011/10/20 06:00 MHDA- 2012/03/01 06:00 CRDT- 2011/10/20 06:00 PHST- 2011/10/20 06:00 [entrez] PHST- 2011/10/20 06:00 [pubmed] PHST- 2012/03/01 06:00 [medline] AID - 10.1055/s-0031-1287793 [doi] PST - ppublish SO - Horm Metab Res. 2011 Oct;43(11):766-73. doi: 10.1055/s-0031-1287793. Epub 2011 Oct 18.